Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features

Discussion DNER ataxia is a treatable condition in which nearly a third of patients have a favorable outcome. DNER antibodies bind to the surface of Purkinje cells and are therefore potentially pathogenic, supporting the use of B-cell–targeting treatments.

http://nn.neurology.org/cgi/content/short/9/5/e200018?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - August 8, 2022 Category: Neurology Authors: Peter, E., Do, L. D., Hannoun, S., Muniz-Castrillo, S., Vogrig, A., Wucher, V., Pinto, A.-L., Chounlamountri, N., Zakaria, W., Rogemond, V., Picard, G., Hedou, J.-J., Ambati, A., Alentorn, A., Traverse-Glehen, A., Manto, M., Psimaras, D., Mignot, E., Cott Tags: RESEARCH ARTICLE Source Type: research